Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non–small-cell lung cancer

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

1987 • 11,429 citations

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

1990 • 3,817 citations

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

1992 • 1,063 citations

c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

1994 • 981 citations

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1992 • 855 citations

bcl-2 Protein in Non-Small-Cell Lung Carcinoma

1993 • 684 citations

Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.

1990 • 622 citations

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.

1989 • 592 citations

bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.

1995 • 578 citations

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.

1992 • 466 citations

Bcl-2 protein expression and long-term survival in breast cancer.

1994 • 404 citations

Survival in early-stage non-small cell lung cancer

1995 • 372 citations

Immunocytochemical markers in stage I lung cancer: relevance to prognosis.

1997 • 313 citations

Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.

1993 • 262 citations

The international system for staging lung cancer

2000 • 219 citations

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer

1995 • 201 citations

Bcl‐2 proto‐oncogene expression in epstein‐barr‐virus‐associated nasopharyngeal carcinoma

1993 • 198 citations

Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.

1997 • 169 citations

Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.

1994 • 139 citations

Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers.

1996 • 133 citations

Do Molecular Markers Predict Survival in Non–Small-Cell Lung Cancer?

1998 • 106 citations

The prognostic significance of p53 andbcl-2 expression in lung adenocarcinoma and its correlation with ki-67 growth fraction

1997 • 100 citations

Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.

1998 • 72 citations

Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.

1996 • 64 citations

Loss of Heterozygosity at the bcl‐2 Gene Locus and Expression of bcl‐2 in Human Gastric and Colorectal Carcinomas

1994 • 60 citations

Time trends and survival after operations for primary lung cancer from 1976 through 1990

1996 • 56 citations

Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: Analysis of 427 cases

1997 • 54 citations

Correlation of Intratumoral Microvessel Density and p53 Protein Overexpression in Human Colorectal Adenocarcinoma

1996 • 49 citations

Tumour staging and classification in lung cancer summary of the International Symposium

2000 • 28 citations

Immunohistochemical detection of p53 protein and prognosis of surgically resected non-small-cell lung cancer.

1997 • 8 citations

Molecular biologic features of non-small cell lung cancer. Clinical implications

1995 • 5 citations